Gloviczki P, Hollier L H, Hoffman E A, Plate G, Trastek V F, Kaye M P
J Thorac Cardiovasc Surg. 1984 Aug;88(2):253-8.
Previous reports have advocated preclotting and autoclaving of Dacron grafts to prevent graft hemorrhage, yet no data delineate possible changes in surface thrombogenicity or thromboembolic risks. To assess these factors, preclotted and preclotted-autoclaved woven Dacron prostheses were implanted in the thoracic aorta of 31 dogs. Grafts were harvested 1 week to 1 month following implantation, and the thrombus-free surface of each graft was calculated by computerized morphometry. Values for thrombus-free surface were lowest in autoclaved grafts preclotted in nonheparinized blood (72%) or in heparinized blood (78%). Grafts preclotted in platelet-rich plasma and autoclaved had a thrombus-free surface value of 85%. Regular preclotted grafts or grafts without preclotting had the greatest thrombus-free surface value (97% and 99%). Distal embolization to the kidneys was detected in seven of 31 animals (23%). No emboli were found in animals with grafts that were not preclotted or if grafts were preclotted with platelet-rich plasma and autoclaved. Thrombus-free surface values were lower (p less than 0.01) in grafts with embolic complications (71% versus 91%). These data suggest that, if the risk of severe bleeding in fully heparinized patients precludes the use of a woven Dacron graft without preclotting, autoclaving a graft preclotted with platelet-rich plasma appears to be the method of choice.
先前的报告主张对涤纶移植物进行预凝血和高压灭菌以防止移植物出血,但尚无数据描述其表面血栓形成性或血栓栓塞风险的可能变化。为评估这些因素,将预凝血和预凝血-高压灭菌的编织涤纶假体植入31只犬的胸主动脉。植入后1周~1个月采集移植物,通过计算机形态测定法计算每个移植物的无血栓表面。在未肝素化血液(72%)或肝素化血液(78%)中预凝血的高压灭菌移植物,其无血栓表面值最低。在富含血小板血浆中预凝血并高压灭菌的移植物,其无血栓表面值为85%。常规预凝血移植物或未预凝血移植物的无血栓表面值最大(分别为97%和99%)。31只动物中有7只(23%)检测到肾脏远端栓塞。在未预凝血移植物的动物中或移植物在富含血小板血浆中预凝血并高压灭菌的动物中未发现栓子。有栓塞并发症的移植物,其无血栓表面值较低(p<0.01)(71%对91%)。这些数据表明,如果在充分肝素化的患者中严重出血的风险排除了使用未预凝血的编织涤纶移植物,那么对在富含血小板血浆中预凝血的移植物进行高压灭菌似乎是首选方法。